These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 800400)

  • 1. The comparative effectiveness of rabbit anti-mouse thymocyte sera in potentiating the survival of mouse skin or tumour allografts made across the H-2 barrier.
    Lai T; Symes MO
    Immunology; 1976 Jul; 31(1):21-6. PubMed ID: 800400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit anti-mouse thymocyte antibody as an adjuvant in the preparation of further anti-thymocyte sera.
    Lai T; Symes MO
    Immunology; 1977 Sep; 33(3):387-90. PubMed ID: 302825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of histocompatibility and antithymocyte serum on the ability of alloantigenic pretreatment to prolong the survival of mouse skin grafts.
    Cohen N; Latorre JA
    Folia Biol (Praha); 1975; 21(1):33-42. PubMed ID: 1091518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of tissue culture on corneal immunogenicity.
    Gabric N; Dekaris I; Suman L; Karaman Z; Mravicic I
    Exp Eye Res; 1999 Mar; 68(3):277-82. PubMed ID: 10079135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of ATS and passive and active enhancement on heart and skin allografts in rats.
    Rowiński WA; Wasowska BA; Ryffa T; Stepkowski S; Dabrowski M; Tilney NL; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):809-17. PubMed ID: 6378133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6-mercaptopurine-rabbit-anti-mouse lymphocyte globulin on the survival of skin allografts in mice.
    Hilgert I; Malberg K; Matthes K; Ambrosius H
    Folia Biol (Praha); 1982; 28(1):22-7. PubMed ID: 7040118
    [No Abstract]   [Full Text] [Related]  

  • 9. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of penicillin on skin graft survival in mice.
    Gończowski L; Turowski G
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):351-6. PubMed ID: 6395827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antilymphocyte sera on bone marrow allograft rejection.
    Riches AC; Thomas DB
    Exp Hematol; 1975 Jun; 3(3):169-80. PubMed ID: 1098919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on suppressor T cells in mice unresponsive to H-2-incompatible skin grafts.
    Kilshaw PJ; Brent L
    Transplant Proc; 1977 Mar; 9(1):717-9. PubMed ID: 325804
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo induction of suppressor activity with rabbit antimouse thymocyte serum (ATS) and antigen.
    Simpson M; Tuttle S; Gozzo JJ
    Transplant Proc; 1977 Mar; 9(1):1041-4. PubMed ID: 325731
    [No Abstract]   [Full Text] [Related]  

  • 15. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and immunosuppressive potency of equine anti-human thymocyte membrane IgG.
    Diethelm AG; Chambers LM; Balch CM; Phillips SJ
    Postgrad Med J; 1976; 52(5 Suppl):55-8. PubMed ID: 825846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
    Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
    J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the mechanism of chronic graft rejection in mice.
    Végh P; Jánossy T; Erdös E
    Acta Chir Hung; 1983; 24(4):329-37. PubMed ID: 6367324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.